NASDAQ · IBB

iShares Biotechnology ETF (IBB)

$210.71+0.45%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$210.71▲ 47.96% in range
Sep 29, 2025Low $142.41 · High $216.96Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

iShares Biotechnology ETF closed at $210.71 on Sep 28, up 0.45%, 2.9% below its 52-week closing high. Volume of 816.7K shares was 0.54× its 20-day average (below normal).

Split-adjusted performance: -1.9% over one month, +31.4% over six months, +51.5% over one year.

Short interest was 12.3M shares at the Sep 15 settlement, up 11.7% from the prior report (7.8 days to cover).

Market cap$10.76B51.0M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield0.02%$0.0112 last paid
52-week range139.07 – 216.96−2.9% from high
Volume816.7K0.54× 20-day avg
Volatility · 60d24.1%Annualised
Short % of float—7.9 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +1.7%1M −1.9%3M +11.0%6M +31.4%YTD +24.9%1Y +51.5%3Y +71.2%5Y +24.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short12.3M+11.7% vs prior
Days to cover7.9Settled Sep 15
% of float—
Short vol. 10d42.9%of daily volume

Quick answers

What is IBB's market cap?
$10.76B, based on the Sep 28 close of $210.71.
Does iShares Biotechnology ETF pay a dividend?
Yes. The latest regular dividend was $0.0112 per share (ex-date Sep 15), an annualised yield of 0.02%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology